Priya Vakharia, MD - The Long View in Neovascular Age-Related Macular Degeneration: Practical Insights on Long-Acting Anti-VEGF Treatment

David S. Boyer, MD / Irving Posalski, MD - PCP-Specialists Share a Lens to Magnify Outcomes With VEGF-Targeting Agents for DME

Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician

Diana V. Do, MD - An Eye Toward Improving the Management of DME: Diagnosis and Shared Decision-Making

Talia Kaden, MD - Considerations for Identifying the Right Patient for Intravitreal Anti-VEGF Injections in nAMD

Diana V. Do, MD / Michael A. Singer, MD - An Eye Toward Improving Outcomes in DME: Timely Diagnosis and Reduced Treatment Burden With Longer-Acting Anti-VEGF Agents

David S. Boyer, MD - An Eye Toward Improving Adherence: Easing the DME Treatment Burden With Longer-Acting Anti-VEGF Agents

W. Lloyd Clark, MD - The Urgency of Retinal Vein Occlusion: Timely Detection, Referral, and Management

Yasha Modi, MD / Christina Y. Weng, MD, MBA - Weighing Out the Risks and Benefits of Intravitreal Anti-VEGF Injections for nAMD

Christine E. Jones, BMBS, PhD - Preventing Congenital Cytomegalovirus Through Behavioral and Emerging Vaccination Strategies

George Oral Waring IV, MD, FACS - Up Close With Presbyopia: Novel Emerging Miotic Agents for Aging Eyes

Diana V. Do, MD - Bringing Anti-VEGF Therapy into Focus: Comparing and Integrating Treatments for Retinal Vein Occlusion

Christina Y. Weng, MD, MBA - A Window Into the Diabetic Eye: Strategies to Optimize the Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema

Nancy M. Holekamp, MD - Eyeing the Benefits and Risks of VEGF-Targeted Therapies for nAMD

W. Lloyd Clark - A Close-Up on VEGF-Targeted Therapies in Diabetic Retinopathy and Diabetic Macular Edema

Adam S. Wenick, MD, PhD - Keeping Sight of Adherence with VEGF-Targeted Therapy: Individualized Dosing Strategies to Improve Care for nAMD